These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 2506929)

  • 1. Analysis of the reversible binding of virginiamycin M to ribosome and particle functions after removal of the antibiotic.
    Nyssen E; Di Giambattista M; Cocito C
    Biochim Biophys Acta; 1989 Sep; 1009(1):39-46. PubMed ID: 2506929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The molecular basis of the inhibitory activities of type A and type B synergimycins and related antibiotics on ribosomes.
    Di Giambattista M; Chinali G; Cocito C
    J Antimicrob Chemother; 1989 Oct; 24(4):485-507. PubMed ID: 2515187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lasting damage to bacterial ribosomes by reversibly bound virginiamycin M.
    Parfait R; Cocito C
    Proc Natl Acad Sci U S A; 1980 Sep; 77(9):5492-6. PubMed ID: 6776538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetics of binding of macrolides, lincosamides, and synergimycins to ribosomes.
    Di Giambattista M; Engelborghs Y; Nyssen E; Cocito C
    J Biol Chem; 1987 Jun; 262(18):8591-7. PubMed ID: 3110150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Action of ions and pH on the binding of virginiamycin S to ribosomes.
    Di Giambattista M; Cocito C
    Biochim Biophys Acta; 1983 May; 757(1):92-100. PubMed ID: 6404307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antagonistic interactions of macrolides and synergimycins on bacterial ribosomes.
    Di Giambattista M; Vannuffel P; Sunazuka T; Jacob T; Omura S; Cocito C
    J Antimicrob Chemother; 1986 Sep; 18(3):307-15. PubMed ID: 3095298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of polypeptide synthesis in cell-free systems by virginiamycin S and erythromycin. Evidence for a common mode of action of type B synergimycins and 14-membered macrolides.
    Chinali G; Nyssen E; Di Giambattista M; Cocito C
    Biochim Biophys Acta; 1988 Jan; 949(1):71-8. PubMed ID: 3120788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluorescence stopped flow analysis of the interaction of virginiamycin components and erythromycin with bacterial ribosomes.
    Moureau P; Engelborghs Y; Di Giambattista M; Cocito C
    J Biol Chem; 1983 Dec; 258(23):14233-8. PubMed ID: 6417137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of fluorescence quenching of ribosome-bound virginiamycin S.
    Di Giambattista M; Ide G; Engelborghs Y; Cocito C
    J Biol Chem; 1984 May; 259(10):6334-9. PubMed ID: 6427212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A spectrofluorimetric study of the interaction between virginiamycin S and bacterial ribosomes.
    Parfait R; de Béthune MP; Cocito C
    Mol Gen Genet; 1978 Oct; 166(1):45-51. PubMed ID: 105239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemical probing of a virginiamycin M-promoted conformational change of the peptidyl-transferase domain.
    Vannuffel P; Di Giambattista M; Cocito C
    Nucleic Acids Res; 1994 Oct; 22(21):4449-53. PubMed ID: 7971275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory action of virginiamycin components on cell-free systems for polypeptide formation from Bacillus subtilis.
    Cocito C; Vanlinden F
    Arch Microbiol; 1983 Aug; 135(1):8-11. PubMed ID: 6414432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular mechanism of action of virginiamycin-like antibiotics (synergimycins) on protein synthesis in bacterial cell-free systems.
    Cocito C; Chinali G
    J Antimicrob Chemother; 1985 Jul; 16 Suppl A():35-52. PubMed ID: 3932310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Affinity labeling of the virginiamycin S binding site on bacterial ribosome.
    Di Giambattista M; Nyssen E; Pecher A; Cocito C
    Biochemistry; 1990 Oct; 29(39):9203-11. PubMed ID: 2125475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The lasting ribosome alteration produced by virginiamycin M disappears upon removal of certain ribosomal proteins.
    Moureau P; Di Giambattista M; Cocito C
    Biochim Biophys Acta; 1983 Mar; 739(2):164-72. PubMed ID: 6402016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Competition between erythromycin and virginiamycin for in vitro binding to the large ribosomal subunit.
    Parfait R; Di Giambattista M; Cocito C
    Biochim Biophys Acta; 1981 Jul; 654(2):236-41. PubMed ID: 6793070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of rRNA bases in the interaction of peptidyltransferase inhibitors with bacterial ribosomes.
    Vannuffel P; Di Giambattista M; Cocito C
    J Biol Chem; 1992 Aug; 267(23):16114-20. PubMed ID: 1644798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Action of erythromycin and virginiamycin S on polypeptide synthesis in cell-free systems.
    Chinali G; Nyssen E; Di Giambattista M; Cocito C
    Biochim Biophys Acta; 1988 Nov; 951(1):42-52. PubMed ID: 3142522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Localization of virginiamycin S binding site on bacterial ribosome by fluorescence energy transfer.
    Di Giambattista M; Thielen AP; Maassen JA; Möller W; Cocito C
    Biochemistry; 1986 Jun; 25(12):3540-7. PubMed ID: 3087416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction between virginiamycin S and ribosomes is partly provided by a salt bridge with a Mg2+ ion.
    Di Giambattista M; Engelborghs Y; Nyssen E; Clays K; Cocito C
    Biochemistry; 1991 Jul; 30(29):7277-82. PubMed ID: 1906740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.